Cervix smear abnormalities: Linking pathology data in female twins, their mothers and sisters

European Journal of Human Genetics

Volumn 19, Issue 1, 2011, Pages 108-111

  Vink, Jacqueline M ^a   Van Kemenade, Folkert J ^b   Meijer, Chris J L M ^b   Casparie, Mariel K ^c   Meijer, Gerrit A ^b   Boomsma, Dorret I ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Foundation PALGA   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DIZYGOTIC TWINS; ENVIRONMENTAL FACTOR; FEMALE; GENE CLUSTER; GENETIC VARIABILITY; HEREDITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MASS SCREENING; MEDICAL LIABILITY; MONOZYGOTIC TWINS; MOTHER; NETHERLANDS; PRIORITY JOURNAL; RELATIVE; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VAGINA SMEAR;

HUMAN PAPILLOMAVIRUS;

EID: 85027923984     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2010.139     Document Type: Article

References (37)

1. Anttila A, Ronco G, Clifford G et al: Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer 2004; 91: 935-941.
2. Gustafsson L, Ponten J, Zack M, Adami HO: International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 1997; 8: 755-763.
3. Yoder L, Rubin M: The epidemiology of cervical cancer and its precursors. Oncol Nurs Forum 1992; 19: 485-493.
4. Van Der Aa MA, Pukkala E, Coebergh JW, Anttila A, Siesling S: Mass screening programmes and trends in cervical cancer in Finland and the Netherlands. Int J Cancer 2008; 122: 1854-1858.
5. Boot HJ, Wallenburg I, Melker HE et al: Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands. Vaccine 2007; 25: 6245-6256.
6. Couto E, Hemminki K: Heritable and environmental components in cervical tumors. Int J Cancer 2006; 119: 2699-2701.
7. Hemminki K, Chen B: Familial Risks for Cervical Tumors in Full and Half Siblings: Etiologic Apportioning. Cancer Epidemiol Biomarkers Prev 2006; 15: 1413-1414.
8. Hemminki K, Li X, Mutanen P: Familial risks in invasive and in situ cervical cancer by histological type. Eur J Cancer Prev 2001; 10: 83-89.
9. Magnusson PKE, Lichtenstein P, Gyllensten UB: Heritability of cervical tumours. Int J Cancer 2000; 88: 698-701.
10. Zelmanowicz AM, Schiffman M, Herrero R et al: Family history as a co-factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: results from two studies conducted in Costa Rica and the United States. Int J Cancer 2005; 116: 599-605.
11. Lichtenstein P, Holm NV, Verkasalo PK et al: Environmental and Heritable Factors in the Causation of Cancer - Analyses of Cohorts of Twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 78-85.
12. Ahlbom A, Lichtenstein P, Malmstrom H, Feychting M, Hemminki K, Pedersen NL: Cancer in twins: genetic and nongenetic familial risk factors. J Natl Cancer Inst 1997; 89: 289-293.
13. Boomsma DI, Vink JM, Van Beijsterveldt CEM et al: Netherlands Twin Register: a focus on longitudinal research. Twin Res 2002; 5: 401-406.
14. Casparie M, Tiebosch A, Burger G et al: Pathology databanking and biobanking in The Netherlands a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cellular Oncology 2007; 29: 19-24.
15. Van Ballegooijen M, Hermens R: Cervical cancer screening in the Netherlands. European Journal of Cancer 2000; 36: 2244-2246.
16. Rebolj M, Van Ballegooijen M, Berkers LM, Habbema D: Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands. Int J Cancer 2006; 120: 806-812.
17. Boomsma DI, de Geus EJC, Vink JM et al: Netherlands Twin Register: from twins to twin families. Twin Research and Human Genetics 2006; 9: 849-857.
18. Bulk S, Van Kemenade FJ, Rozendaal L, Meijer CJLM: The Dutch CISOA-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J Clin Pathol 2004; 57: 388-393.
19. Falconer DS, Mackay TFC: Treshold Characters (Chapter 18), in Quantitative Genetics. Longman Group Ltd.: Essex, 1996.
20. Neale MC, Boker SM, Xie G, Maes HH: Mx: Statistical Modeling. 5th edn. VCU Box 900126: Richmond, VA 23298, 1999.
21. Boomsma DI, Busjahn A, Peltonen L: Classical twin studies and beyond. Nat Rev Genet 2002; 3: 872-882.
22. Gök M, Heideman DA, Van Kemenade FJ et al: HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. Britisch Medical Journal 2010; 11: c1040.
23. McCredie MR, Sharples KJ, Paul D et al: Natural history of cervical neoplasia and risk of invasive cancer in women with 3: a retrospective cohort study. Lancet Oncol 2008; 9: 425-434.
24. Czene K, Lichtenstein P, Hemminki K: Environmental and heritable causes of cancer among 9.6 million individuals in the swedish family-cancer database. Int J Cancer 2002; 99: 260-266.
25. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338: 423-428.
26. Nobbenhuis MA, Helmerhorst TJ, Van den Brule AJ et al: Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear. The Lancet 2001; 358: 1782-1783.
27. De Araujo Souza PS, Villa LL: Genetic susceptibility to infection with human papillo-mavirus and development of cervical cancer in women in Brazil. Muation Research 2003; 544: 375-383.
28. Koshiol J, Hildesheim A, Gonzalez P et al: Common Genetic Variation in TP53 and Risk of Human Papillomavirus Persistence and Progression to CIN3/Cancer Revisited. Cancer Epidemiol Biomarkers Prev 2009; 18: 1631-1637.
29. Simões RT, Gonçalves MA, Castelli EC et al: HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus. Mod Pathol 2009; 22: 1075-1082.
30. Au WW: Life style, environmental and genetic susceptibility to cervical cancer. Toxicology 2004; 198: 117-120.
31. Nishino K, Sekine M, Kodama S et al: Cigarette smoking and glutathione S-transferase M1 polymorphism associated with risk for uterine cervical cancer. J Obstet Gynaecol Res 2008; 34: 994-1001.
32. Bosch FX, de Sanjose S: The epidemiology of human papillomavirus infection and cervical cancer. Dis markers 2007; 23: 213-227.
33. Cotton SC, Sharp L, Masson LF et al: Lifestyle and socio-demographic factors associated with high-risk HPV infection in UK women. Br J Cancer 2007; 97: 133-139.
34. Vink JM, Willemsen G, Boomsma DI: Heritability of smoking initiation and nicotine dependence. Behav Genet 2005; 35: 397-406.
35. Stubbe JH, Boomsma DI, Vink JM et al: Genetic influence on exercise participation in 37,051 twin pairs from seven countries. PLos ONE 2006; 20: e22.
36. Verweij K, Zietsch BP, Bailey JM, Martin NG: Shared etiology of risky sexual behaviour and adolescent misconduct: genetic and environmental influences. Genes, Brains and Behavior 2009; 8: 107-113.
37. Zietsch BP, Verweij K, Bailey AJ, Wright MJ, Martin NG: Genetic and environmental influences on risky sexual behavior and its relationship with personality. Behav Genet 2010; 40: 12-21.